These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31533230)

  • 1. The Inhibitory Effect of Protamine on Platelets is Attenuated by Heparin without Inducing Thrombocytopenia in Rodents.
    Miklosz J; Kalaska B; Kaminski K; Rusak M; Szczubialka K; Nowakowska M; Pawlak D; Mogielnicki A
    Mar Drugs; 2019 Sep; 17(9):. PubMed ID: 31533230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Andexanet Alfa, the Possible Alternative to Protamine for Reversal of Unfractionated Heparin.
    Maneno JN; Ness GL
    Ann Pharmacother; 2021 Feb; 55(2):261-264. PubMed ID: 32667214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Hirsh J; Raschke R
    Chest; 2004 Sep; 126(3 Suppl):188S-203S. PubMed ID: 15383472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-protamine-heparin antibodies: incidence, clinical relevance, and pathogenesis.
    Bakchoul T; Zöllner H; Amiral J; Panzer S; Selleng S; Kohlmann T; Brandt S; Delcea M; Warkentin TE; Sachs UJ; Greinacher A
    Blood; 2013 Apr; 121(15):2821-7. PubMed ID: 23325832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-protamine balance after neonatal cardiopulmonary bypass surgery.
    Peterson JA; Maroney SA; Zwifelhofer W; Wood JP; Yan K; Bercovitz RS; Woods RK; Mast AE
    J Thromb Haemost; 2018 Oct; 16(10):1973-1983. PubMed ID: 30016577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protamine reduces whole blood platelet aggregation after cardiopulmonary bypass.
    Olsson A; Alfredsson J; Håkansson E; Svedjeholm R; Berglund J; Berg S
    Scand Cardiovasc J; 2016; 50(1):58-63. PubMed ID: 26402229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo neutralization of unfractionated heparin and low-molecular-weight heparin by a novel salicylamide derivative.
    Kuziej J; Litinas E; Hoppensteadt DA; Liu D; Walenga JM; Fareed J; Jeske W
    Clin Appl Thromb Hemost; 2010 Aug; 16(4):377-86. PubMed ID: 20460347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management of heparin-induced thrombocytopenia.
    Keeling D; Davidson S; Watson H;
    Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban.
    Koster A; Kukucka M; Bach F; Meyer O; Fischer T; Mertzlufft F; Loebe M; Hetzer R; Kuppe H
    Anesthesiology; 2001 Feb; 94(2):245-51. PubMed ID: 11176088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High incidence of antibodies to protamine and protamine/heparin complexes in patients undergoing cardiopulmonary bypass.
    Lee GM; Welsby IJ; Phillips-Bute B; Ortel TL; Arepally GM
    Blood; 2013 Apr; 121(15):2828-35. PubMed ID: 23422751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamic characterization of the interaction between abciximab or tirofiban with unfractionated or a low molecular weight heparin in healthy subjects.
    Klinkhardt U; Graff J; Westrup D; Kirchmaier CM; Esslinger HU; Breddin HK; Harder S
    Br J Clin Pharmacol; 2001 Sep; 52(3):297-305. PubMed ID: 11560562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
    Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C
    Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of Protamine Administration for Prevention of Bleeding Complications in Patients Undergoing TAVR.
    Al-Kassou B; Kandt J; Lohde L; Shamekhi J; Sedaghat A; Tabata N; Weber M; Sugiura A; Fimmers R; Werner N; Grube E; Treede H; Nickenig G; Sinning JM
    JACC Cardiovasc Interv; 2020 Jun; 13(12):1471-1480. PubMed ID: 32553337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protamine-induced immune thrombocytopenia.
    Singla A; Sullivan MJ; Lee G; Bartholomew J; Kapadia S; Aster RH; Curtis BR
    Transfusion; 2013 Oct; 53(10):2158-63. PubMed ID: 23384227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Adjusted Calculation Model Allows for Reduced Protamine Doses without Increasing Blood Loss in Cardiac Surgery.
    Kjellberg G; Sartipy U; van der Linden J; Nissborg E; Lindvall G
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):487-93. PubMed ID: 26270199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of bivalirudin and unfractionated heparin plus protamine in patients with coronary heart disease undergoing percutaneous coronary intervention (from the Antithrombotic Regimens aNd Outcome [ARNO] trial).
    Parodi G; Migliorini A; Valenti R; Bellandi B; Signorini U; Moschi G; Buonamici P; Cerisano G; Antoniucci D
    Am J Cardiol; 2010 Apr; 105(8):1053-9. PubMed ID: 20381652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatan sulfate: an alternative to unfractionated heparin for anticoagulation in hemodialysis patients.
    Vitale C; Berutti S; Bagnis C; Soragna G; Gabella P; Fruttero C; Marangella M
    J Nephrol; 2013; 26(1):158-63. PubMed ID: 22419236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifactor Xa Activity for the Management of Anticoagulation during Cardiac Surgery.
    Reyher C; Würfel C; Lindhoff-Last E; Meybohm P; Zacharowski K; Moritz A; Schindewolf M; Weber CF
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):494-500. PubMed ID: 26757210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients.
    Junqueira DR; Zorzela LM; Perini E
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD007557. PubMed ID: 28431186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin and protamine titration do not improve haemostasis in cardiac surgical patients.
    Shore-Lesserson L; Reich DL; DePerio M
    Can J Anaesth; 1998 Jan; 45(1):10-8. PubMed ID: 9466020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.